Clinical improvement of adrenoleukodystrophy following intravenous gammaglobulin therapy

T Miike; K Taku; T Tamura; J Ohta; M Ozaki; C Yamamoto; T Sakai; Y Antoku; C Yadomi

doi:10.1016/s0387-7604(89)80083-x

Clinical improvement of adrenoleukodystrophy following intravenous gammaglobulin therapy

Brain Dev. 1989;11(2):134-7. doi: 10.1016/s0387-7604(89)80083-x.

Authors

T Miike¹, K Taku, T Tamura, J Ohta, M Ozaki, C Yamamoto, T Sakai, Y Antoku, C Yadomi

Affiliation

¹ Department of Child Development, Kumamoto University Medical School, Japan.

PMID: 2469340
DOI: 10.1016/s0387-7604(89)80083-x

Abstract

A patient with adrenoleukodystrophy was successfully treated by means of intravenous gammaglobulin injections. The clinical symptoms, especially visual loss, were apparently relieved and no neurological deterioration was observed during a 18-month period following the start of the gammaglobulin treatment.

Publication types

Case Reports

MeSH terms

Adolescent
Adrenoleukodystrophy / diagnostic imaging
Adrenoleukodystrophy / drug therapy
Adrenoleukodystrophy / immunology*
Diffuse Cerebral Sclerosis of Schilder / immunology*
Erythrocytes / cytology
Erythrocytes / metabolism
Fatty Acids / metabolism
Fibroblasts / cytology
Fibroblasts / metabolism
Humans
Injections, Intravenous
Male
Tomography, X-Ray Computed
gamma-Globulins / administration & dosage
gamma-Globulins / therapeutic use*

Substances

Fatty Acids
gamma-Globulins